Potential Efficacy of Citicoline as Adjunct Therapy in Treatment of Cerebral Malaria
- Publication Type:
- Journal Article
- Antimicrobial Agents and Chemotherapy, 2014, 58 (1), pp. 602 - 605
- Issue Date:
Files in This Item:
|Potential Efficacy of Citicoline as Adjunct Therapy in Treatment of.pdf||Published Version||358.78 kB|
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Cerebral malaria (CM) is characterized by a dysregulated immune response that results in endothelial membrane destabilization and increased microparticle (MP) production. Citicoline (CTC) is a membrane stabilizer used for the treatment of neurological disorders. We evaluated the efficacy of CTC as adjunct therapy to aid recovery from experimental CM. We show that CTC reduces MP production in vitro; in combination with artesunate in vivo, confers partial protection against CM; and prolongs survival. © 2014, American Society for Microbiology. All Rights Reserved.
Please use this identifier to cite or link to this item: